The present invention relates to pharmaceutical suspensions comprising multimeric multiepitope influenza polypeptides to processes for their production and to their use as immunizing subjects against influenza. In particular the invention relates to stable aqueous microparticulate suspensions comprising a multimeric multiepitope polypeptide.